RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).

A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).

Add to Collection
2007 Nov-Dec Others Fist_Author_Year_PM

Full Author : ['Nagpal, Manish', 'Nagpal, Kamal', 'Nagpal, P N']
Journal Title : Indian journal of ophthalmology
Chapter : Section3
Journal Year : 2007
Cited by : Not Available

Wet age-related macular degeneration and diabetic retinopathy are pathological consequences of vascular endothelial growth factor (VEGF) release as a reaction to deficiency of oxygen and nutrients in the macular cells. Conventional treatment modalities ha.....

Keywords : ["various antivascular endothelial growth factor drug pegaptanib sodium macugen ranibizumab lucentis", "comparative debate", "bevacizumab avastin"]